Chianelli, M;
Busetto, L;
Vettor, R;
Annibale, B;
Paoletta, A;
Papini, E;
Albanese, A;
Carabotti, M;
Casarotto, D;
De Pergola, G;
Disoteo, O E;
Grandone, I;
Medea, G;
Nisoli, E;
Raffaelli, M;
Schiff, S;
Vignati, F;
Cinquini, M;
Gonzalez-Lorenzo, M;
Fittipaldo, V A;
Minozzi, S;
Monteforte, M;
Tralongo, A C;
Novizio, R;
Persichetti, A;
Samperi, I;
Scoppola, A;
Borretta, G;
Carruba, M;
Carbonelli, M G;
De Luca, M;
Frontoni, S;
Corradini, S. G;
Muratori, F;
Attanasio, R.
This guideline (GL) is aimed at providing a clinical practice reference for the management of adult patients with overweight or obesity associated with metabolic complications who are resistant to lifestyle modification.
Surgeons, endocrinologists, gastroenterologists, psychologists, pharmacologists, a g...
Pharmacological management of obesity improves outcomes and decreases the risk of obesity-related complications. This American Gastroenterological Association guideline is intended to support practitioners in decisions about pharmacological interventions for overweight and obesity. A multidisciplinary pa...
Pharmacological treatments are an effective and scalable approach to treating obesity. As with any chronic disease, such as type 2 diabetes (T2DM) or hypertension, pharmacotherapy is an important pillar in the management of obesity.
The focus of obesity management should be the improvement of health para...
OBJECTIVE: To formulate clinical practice guidelines for the pharmacological management of obesity. PARTICIPANTS: An Endocrine Society-appointed Task Force of experts, a methodologist, and a medical writer. This guideline was co-sponsored by the European Society of Endocrinology and The Obesity Society. ...
